Multiple Sclerosis (MS)

Introduction

Multiple sclerosis, usually called MS, is a long-term condition that affects the brain, spinal cord, and the nerves that connect them to the rest of the body. If you have recently been diagnosed, or if a doctor is investigating MS as the cause of your symptoms, you are likely facing a lot of new information at once — new medical terms, choices about treatment, questions about work and family, and uncertainty about what the years ahead will look like.

The good news is that the picture for people living with MS has changed substantially over the past two decades. There are now many disease-modifying therapies that can slow the condition down, clearer ways to diagnose it earlier, and a much better understanding of how to manage the day-to-day symptoms. Most people with MS today have a very different long-term outlook than those diagnosed thirty years ago.

This article walks you through what MS is, how it is diagnosed, the different types, the treatments doctors use, and what to expect as you live with the condition over time. It is written for someone who has been diagnosed or who is being assessed, rather than for someone trying to identify their symptoms for the first time.

What Is Multiple Sclerosis?

Multiple sclerosis is a condition of the central nervous system — the brain, spinal cord, and the optic nerves that carry signals from the eyes. In MS, the body’s own immune system attacks the protective coating around nerve fibres, called myelin. Myelin is sometimes compared to the plastic insulation around an electrical wire. It helps nerve signals travel quickly and smoothly. When myelin is damaged, signals slow down, get scrambled, or stop altogether.

The areas where myelin has been damaged are called lesions or plaques. They show up as bright spots on MRI scans of the brain and spinal cord. The word “sclerosis” means scarring, and “multiple” refers to the fact that these scars appear in many different places and at many different times. Over time, the nerve fibres themselves can also become damaged, not just their coating, which is one reason some symptoms can become permanent.

MS is what doctors call an autoimmune condition — the immune system, which normally protects you from infection, mistakenly attacks healthy tissue. The exact reason this happens is not fully understood. MS is not contagious, it is not directly inherited in most cases, and it is not caused by anything a person did or did not do.

The condition usually starts between the ages of 20 and 40, though it can begin in childhood or later in life. Women are diagnosed two to three times more often than men. MS is found worldwide, though it appears more commonly in regions farther from the equator.

Types of Multiple Sclerosis

Clinically Isolated Syndrome (CIS)

A clinically isolated syndrome is a first episode of neurological symptoms caused by inflammation and demyelination in the central nervous system. It lasts at least 24 hours. Not everyone who has a CIS goes on to develop MS, but many do, especially when an MRI shows existing lesions. People with CIS are usually monitored closely, and in some cases disease-modifying treatment is started early to reduce the chance of a second attack.

Relapsing-Remitting MS (RRMS)

This is the most common form, accounting for around 85 percent of people with MS at the time of diagnosis. In RRMS, symptoms appear in episodes called relapses or attacks, which develop over days or weeks. After a relapse, symptoms may improve fully, partially, or only over a long period. Between relapses, the condition is generally stable. The time between relapses is called remission.

Secondary Progressive MS (SPMS)

Some people who start with RRMS later move into a phase where symptoms slowly worsen over time, even without distinct relapses. This is called secondary progressive MS. The shift can happen years or decades after the original diagnosis. Modern treatments appear to delay this transition for many people, though it does not stop in everyone.

Primary Progressive MS (PPMS)

About 10 to 15 percent of people have primary progressive MS from the start. Symptoms slowly worsen from the beginning without clear relapses or remissions. PPMS is more often diagnosed in people in their 40s and 50s and affects men and women in roughly equal numbers. Walking difficulty is a particularly common early feature.

Doctors also describe MS as “active” or “not active” (depending on whether there are recent relapses or new MRI lesions) and as “with progression” or “without progression” (depending on whether disability is gradually increasing). These descriptions help fine-tune treatment decisions.

Causes and Risk Factors

The exact cause of MS is not known. Researchers believe it results from a mix of genetic susceptibility and environmental triggers. Several factors have been identified that increase the risk:

• Genetics. Having a close relative with MS slightly raises your risk, though most people with MS have no family history. There is no single “MS gene.” Instead, dozens of small genetic variations seem to nudge the immune system in a direction that makes MS more likely.
• Epstein-Barr virus (EBV). Almost everyone with MS has been infected with EBV, the virus that causes glandular fever (mononucleosis). Large studies have shown that prior EBV infection is now considered a necessary — though not sufficient — factor in developing MS.
• Vitamin D and sunlight. Low vitamin D levels and limited sun exposure, especially in childhood, are linked to higher MS risk. This may help explain why MS is more common at higher latitudes.
• Smoking. Smoking increases both the risk of developing MS and the risk that the condition will progress more quickly.
• Obesity in adolescence. Being overweight in the teenage years is associated with higher MS risk later.
• Sex hormones. Women are affected more often than men, and hormonal factors are thought to play a role, though the details are still being studied.

None of these factors cause MS on their own. They appear to combine in ways that researchers are still working to understand.

Signs and Symptoms

Vision problems

Inflammation of the optic nerve, called optic neuritis, is a frequent early symptom. It often causes blurred vision, pain when moving the eye, and reduced colour vision, usually in one eye. Double vision can also occur.

Sensory symptoms

Numbness, tingling, pins and needles, or a band-like feeling around the chest or limbs are common. Some people describe an electric-shock sensation that runs down the spine when they bend the neck forward, known as Lhermitte’s sign.

Motor symptoms

Weakness in one or more limbs, stiffness (spasticity), and problems with balance and coordination can affect walking. Over time, walking distance and steadiness may change.

Fatigue

MS-related fatigue is one of the most common and most disabling symptoms. It is different from ordinary tiredness — people describe it as a heavy, overwhelming exhaustion that does not improve with rest and that can make even small activities feel difficult.

Bladder, bowel, and sexual symptoms

Urinary urgency, frequency, or incomplete emptying are common. Constipation and changes in sexual function also occur.

Cognitive symptoms

Many people notice slower thinking, difficulty with memory, trouble multitasking, or word-finding problems. These changes are usually subtle but can affect work and daily life.

Mood changes

Depression and anxiety are more common in people with MS than in the general population. This is partly because of the impact of living with a long-term condition and partly because MS itself can affect areas of the brain that regulate mood.

Pain

Pain can come from nerve damage (neuropathic pain), from muscle spasticity, or from changes in how the body moves.

Recognising a relapse

A relapse is a new neurological symptom, or a clear worsening of an old one, that lasts at least 24 hours and is not caused by infection, fever, or another temporary trigger. Relapses usually develop over hours to days and then plateau before slowly improving over weeks. Recognising a relapse early matters because treatment is most useful when started promptly. If you notice a new symptom that persists for more than a day, it is worth contacting your neurology team rather than waiting.

Temporary worsening of existing symptoms in response to heat, exercise, or illness is called a pseudo-relapse. It usually settles once the trigger resolves and does not require relapse treatment, though it is still worth telling your team.

Diagnosis

Diagnosing MS takes time and care because there is no single test that confirms it. Instead, doctors put together information from your history, neurological examination, imaging, and sometimes spinal fluid testing.

Clinical history and examination

A neurologist will ask in detail about your symptoms, when they started, how long they lasted, and whether you have had any earlier episodes you might not have connected to a neurological condition. The examination checks reflexes, strength, sensation, coordination, eye movements, and walking.

MRI scans

Magnetic resonance imaging is the most important tool for diagnosing MS. MRI can show lesions in the brain, spinal cord, and optic nerves. Contrast dye (gadolinium) helps distinguish older lesions from newer, active ones. To meet the diagnostic criteria, lesions need to show evidence of being scattered in space (different parts of the central nervous system) and in time (occurring at different points).

Lumbar puncture

Also called a spinal tap, this test involves taking a small sample of cerebrospinal fluid — the fluid surrounding the brain and spinal cord — through a needle in the lower back. The fluid is checked for oligoclonal bands, which are markers of immune activity in the central nervous system. Their presence supports an MS diagnosis but is not required in every case.

Evoked potentials

These tests measure how quickly nerve signals travel along certain pathways, most commonly the visual pathway. Slowed signals can suggest old or current damage to myelin.

Blood tests

Blood tests do not diagnose MS, but they are used to rule out other conditions that can mimic it, including vitamin B12 deficiency, thyroid problems, infections, and other autoimmune conditions.

The McDonald criteria

Neurologists use a set of internationally agreed rules called the McDonald criteria to make the diagnosis. These were updated in 2017 and combine clinical findings with MRI and spinal fluid results. The criteria allow earlier diagnosis than was possible in the past, which means treatment can often start sooner.

It is worth knowing that being diagnosed with MS can be an emotionally difficult moment, even when it feels like a relief to have an answer. Many MS centres have nurse specialists who help patients understand the diagnosis and plan next steps.

Treatment and Management

There is no cure for MS, but there are several effective ways to manage it. Treatment usually has three goals: reducing the activity of the disease over the long term, treating relapses when they happen, and managing day-to-day symptoms.

Disease-modifying therapies (DMTs)

Disease-modifying therapies are medications that reduce how often relapses occur, lessen the number of new MRI lesions, and, for some, slow the build-up of disability. They do not repair damage that has already happened, which is one reason starting treatment earlier is generally preferred by major neurology societies including the American Academy of Neurology (AAN) and European MS guideline groups.

• Injectable therapies. Interferon beta medications and glatiramer acetate have been used for decades. They have moderate efficacy and a long safety record.
• Oral therapies. These include teriflunomide, dimethyl fumarate, diroximel fumarate, fingolimod, siponimod, ozanimod, ponesimod, and cladribine. They vary in strength and side-effect profile.
• Infused or higher-efficacy therapies. Natalizumab, ocrelizumab, ofatumumab, ublituximab, alemtuzumab, and rituximab (used off-label in many countries) are generally more powerful at suppressing disease activity and are increasingly used earlier in the condition for people with active disease.

Choosing a DMT involves a careful conversation with your neurologist that takes into account how active your MS is, your MRI findings, your age, plans for pregnancy, other health conditions, and how you feel about the route of administration and monitoring requirements. There is no single best DMT for everyone, and the field is moving toward starting with higher-efficacy options for many people rather than gradually escalating from milder treatments — though both approaches remain in use.

Ocrelizumab is the first DMT shown in trials to slow disability progression in primary progressive MS. For other progressive forms, the role of DMTs is more limited, though some agents are used in active SPMS.

Treatment of relapses

When a relapse causes significant new symptoms, doctors often treat with a short course of high-dose corticosteroids, usually methylprednisolone given as tablets or through a vein over three to five days. Steroids do not change the long-term course of MS but can shorten a relapse and help recovery. For severe relapses that do not respond to steroids, plasma exchange (plasmapheresis) is sometimes used.

Not every relapse needs treatment. Mild sensory relapses, for example, often recover on their own. Your neurology team will weigh the severity of symptoms against the side effects of steroids.

Symptom-specific treatments

Many of the day-to-day difficulties of MS can be eased with targeted treatments:

• Spasticity. Medications such as baclofen and tizanidine, stretching, physiotherapy, and, in some cases, botulinum toxin injections or intrathecal baclofen pumps.
• Fatigue. Amantadine, modafinil, and graded exercise programmes are commonly used. Energy-management strategies through occupational therapy can make a significant difference.
• Bladder symptoms. Anticholinergic medications, pelvic floor therapy, intermittent self-catheterisation, and botulinum toxin injections into the bladder for selected patients.
• Pain. Medications for neuropathic pain such as gabapentin, pregabalin, amitriptyline, and duloxetine.
• Walking difficulty. Fampridine (4-aminopyridine) helps some people walk faster. Mobility aids, orthoses, and gait training are also part of the picture.
• Mood and cognition. Antidepressants, talking therapies, and cognitive rehabilitation can all be helpful.

Rehabilitation

Rehabilitation is a core part of MS care, not just an add-on. Physiotherapy, occupational therapy, speech and language therapy, and neuropsychology can each play a role depending on which symptoms are most affecting your life. Even small gains in strength, balance, or strategies for managing fatigue can change daily function meaningfully.

Stem cell transplantation

Autologous haematopoietic stem cell transplantation (aHSCT) involves wiping out the immune system with chemotherapy and rebuilding it from a person’s own stem cells. It is being studied as a treatment for highly active relapsing MS that has not responded to other therapies. Evidence is encouraging in carefully selected patients, but aHSCT carries significant risks and is offered only at specialised centres. It is not currently a routine option for most people with MS.

Lifestyle and Self-Management

How you live alongside MS matters. Several lifestyle factors have evidence behind them as ways to support overall health and, in some cases, the course of the condition itself.

• Exercise. Regular physical activity has been shown to reduce fatigue, improve mood, maintain strength and balance, and support cardiovascular health. A combination of aerobic exercise, strength training, and flexibility work is generally recommended by MS organisations. Activity should be paced to avoid overheating, which can temporarily worsen symptoms.
• Diet. No single diet has been proven to change the course of MS, but a balanced eating pattern — rich in vegetables, fruit, whole grains, legumes, fish, and healthy oils, and limited in processed foods — supports overall health. Maintaining a healthy weight reduces the burden on joints and the heart.
• Vitamin D. Many neurologists check vitamin D levels and recommend supplementation when low. Optimal levels for people with MS are still being researched, but correcting deficiency is widely supported.
• Stopping smoking. Smoking is associated with faster MS progression. Stopping is one of the most impactful changes someone with MS can make for their long-term outlook.
• Sleep. Poor sleep worsens fatigue, mood, and cognition. Treating sleep disorders, including sleep apnoea, can help.
• Heat management. Heat can temporarily worsen MS symptoms, a phenomenon called Uhthoff’s phenomenon. Cooling vests, cold drinks, air conditioning, and exercising in cooler conditions can help.
• Stress management. Stress does not cause MS, but it can make symptoms feel worse. Mindfulness, talking therapy, and social support all have a role.
• Vaccinations. Staying up to date with vaccinations is important. Some DMTs affect how the immune system responds to vaccines, so timing should be discussed with your neurology team.

Monitoring and Follow-Up

Living with MS means regular follow-up, even when things feel stable. Most people are seen by their neurology team at least once a year, and more often when starting a new DMT or after a relapse.

Monitoring typically includes:

• Clinical review of symptoms, mood, and function
• Neurological examination
• MRI scans, usually annually for the first few years on a DMT and then less often if the condition is stable
• Blood tests for safety monitoring, particularly with certain higher-efficacy DMTs
• Discussion of any new symptoms or quality-of-life concerns

Some MS centres use standardised tools like the Expanded Disability Status Scale (EDSS) to track changes in disability over time. These tools are imperfect but help neurologists notice trends.

Complications

Over time, MS can lead to a number of complications, which vary widely between individuals. Some of the more common ones include:

• Reduced mobility. Walking can become more difficult over years or decades, and some people eventually use a stick, walking frame, or wheelchair for some or all of the time.
• Falls and fractures. Balance problems and reduced bone density (sometimes related to steroid use or reduced activity) raise the risk of falls and broken bones.
• Urinary tract infections. Incomplete bladder emptying can lead to repeated infections.
• Pressure sores. For people with significantly reduced mobility, skin breakdown in pressure areas can occur and needs careful prevention.
• Swallowing and speech difficulties. These appear in some people as the condition progresses and benefit from speech and language therapy assessment.
• Mood disorders. Depression is more common in people with MS and can be under-recognised.
• Cognitive change. Some people develop significant difficulties with memory, attention, or processing speed.

Recognising complications early often means they can be addressed before they become more disabling. This is one of the reasons regular review with a neurology team and access to allied health professionals matter.

Living with Multiple Sclerosis

A diagnosis of MS changes plans and prompts a lot of practical questions. The condition is highly variable, and many people continue working, raising families, travelling, and pursuing the things they care about for decades after diagnosis. Some need significant adjustments along the way, and others much fewer.

Work and career

Most people with MS continue to work, at least for many years after diagnosis. Where work becomes difficult, common adjustments include flexible hours, working from home, adjustments to the physical workspace, reduced hours, or a change of role. Occupational therapy assessment can be helpful in identifying useful changes. You are not required to disclose your diagnosis to an employer, though doing so can sometimes unlock workplace support.

Pregnancy and family planning

MS does not generally affect fertility, and pregnancy outcomes for women with MS are usually similar to those without the condition. Relapse rates often fall during pregnancy, particularly in the later months, and may rise again in the months after delivery. Some DMTs are not safe in pregnancy and need to be stopped or switched in advance, while others can be continued or even used during pregnancy in certain situations. Planning pregnancy with your neurologist well in advance is helpful so that DMTs, vitamin levels, and other factors can be optimised.

Breastfeeding is encouraged for most women with MS, and several DMTs are now considered compatible with breastfeeding.

Relationships and intimacy

MS can affect intimate relationships through fatigue, mood changes, sexual symptoms, and the emotional weight of the diagnosis. Open conversation with a partner, and where helpful with a therapist or specialist nurse, can make a real difference. Sexual symptoms are treatable and worth raising with your team, even though they are often left unmentioned.

Driving and travel

Most people with MS continue to drive. Significant visual problems, leg weakness, or cognitive change may make a driving assessment necessary. Travel is usually fine with sensible planning around heat, fatigue, medication storage, and access to medical help if needed during a trip.

Mental health and support

Adjusting emotionally to MS is its own piece of work and can take time. Many people find peer support — either in person or online — valuable. Talking therapies, particularly cognitive behavioural therapy, can help with the anxiety, low mood, and worry about the future that often accompany the condition.

Multiple Sclerosis in Children

MS is mostly a condition of adulthood, but it can begin in childhood or the teenage years. Paediatric MS accounts for around 3 to 5 percent of all MS cases. Almost all children with MS have the relapsing-remitting form.

Children with MS often have more frequent relapses than adults early on, though they typically recover well from each one. Because the condition has more time to act over a lifetime, early and effective treatment is particularly important. Several DMTs are now licensed or studied for use in children, and high-efficacy treatments are increasingly used in paediatric MS centres.

Beyond the medical side, MS in children raises specific issues around school, learning, and emotional development. Cognitive symptoms can affect learning, and fatigue often interferes with school attendance and after-school activities. Schools may need to be informed so that adjustments can be made, such as rest breaks, extra time for tasks, or reduced load during relapses. A paediatric neurology team familiar with MS, working alongside the family and school, makes a significant difference.

Parents often worry about the long-term outlook for a child with MS. While paediatric-onset MS means a longer overall course, modern treatments have meaningfully changed the trajectory, and many young people with MS go on to university, careers, and family life much as their peers do.

Preventing Progression

MS cannot currently be prevented in the first place, but a great deal of MS care is about reducing the chance that the condition will worsen over time. The main strategies are:

• Starting and staying on appropriate DMTs. Treatment adherence has a real impact on long-term outcomes. If side effects or practical issues are making a DMT hard to continue, this is worth raising with your team rather than stopping on your own.
• Switching treatment when needed. Breakthrough relapses or new MRI lesions on a DMT may mean it is time to consider a different therapy.
• Treating comorbidities. Conditions like high blood pressure, diabetes, high cholesterol, depression, and sleep apnoea are more common in people with MS and, when untreated, are linked to faster MS progression.
• Vascular health. Looking after the heart and blood vessels seems to support better brain health in MS.
• Staying active. Maintaining physical activity helps preserve function over time.
• Avoiding tobacco. Stopping smoking is one of the most evidence-based lifestyle changes for MS outcomes.

When to Seek Urgent Care

Most MS symptoms can be managed through routine follow-up. Some situations, however, warrant prompt contact with your neurology team or, in some cases, emergency care:

• New or rapidly worsening neurological symptoms suggestive of a relapse
• Sudden loss of vision in one or both eyes
• Severe weakness, particularly affecting walking or use of the hands
• Inability to pass urine, or sudden loss of bladder or bowel control
• High fever along with worsening neurological symptoms (an infection can mimic or trigger a pseudo-relapse and needs treatment)
• Severe headache that is unusual for you
• Suicidal thoughts or a serious decline in mental health

Some symptoms — sudden severe weakness on one side, slurred speech, a sudden severe headache, or facial droop — should be treated as a possible stroke until proven otherwise, even in someone with known MS. Call emergency services rather than waiting.

Frequently Asked Questions

Will MS shorten my life?

For most people with MS, life expectancy is only modestly reduced compared to the general population, and many live a normal lifespan. Outcomes have improved significantly with modern treatment. Factors like overall health, comorbid conditions, and access to ongoing care matter more for life expectancy than the diagnosis alone.

Will I end up in a wheelchair?

This is one of the most common fears at diagnosis. The honest answer is that MS is highly variable. Some people develop significant mobility difficulty over time; many do not. Most studies suggest that with modern DMTs, the proportion of people reaching severe disability is lower than in previous generations. Your neurology team can give you a more individual sense of your trajectory based on your MRI findings, type of MS, and response to treatment.

Is MS hereditary?

MS is not directly inherited. Having a parent or sibling with MS slightly raises your children’s risk, but the overall risk remains low — in the order of 2 to 4 percent. Most children of people with MS do not develop the condition.

Can I have children if I have MS?

Yes. MS does not generally affect fertility, and pregnancy outcomes are typically good. Planning pregnancy with your neurologist allows DMTs and other factors to be reviewed in advance.

Should I change my diet?

There is no single MS diet proven to change the course of the condition. A balanced eating pattern, rich in vegetables, fruit, whole grains, and healthy fats, supports general health and complements medical treatment.

Will heat or hot weather damage my MS?

Heat can make MS symptoms temporarily worse but does not cause new damage. Symptoms typically return to baseline once you cool down. Heat sensitivity is variable and tends to lessen with simple cooling strategies.

Can I exercise with MS?

Yes, and exercise is encouraged. It improves fatigue, strength, balance, and mood. The type and intensity of activity should be paced to your individual situation, and a physiotherapist familiar with MS can help build a sustainable programme.

Do I have to take a DMT?

DMTs are not mandatory, but they are recommended by major neurology societies for most people with active relapsing MS because of their effect on long-term outcomes. The decision is yours to make with your neurologist, and reasons for choosing or declining a particular medication are worth discussing openly.

Will my symptoms always come back after a relapse?

Recovery from relapses varies. Early in the condition, many people recover fully or nearly so. Later relapses may leave more lasting symptoms. Prompt treatment, rehabilitation, and disease-modifying therapy all influence recovery.

Is there a cure on the horizon?

There is no cure for MS at the moment, but research is moving quickly. New medications, remyelination therapies aimed at repairing damaged myelin, and approaches like stem cell transplantation are all being studied. The treatments available today are dramatically better than those available even fifteen years ago.

Conclusion

Multiple sclerosis is a long-term condition, but it is one in which the medical landscape has changed enormously in recent years. Earlier diagnosis, a wide range of disease-modifying therapies, well-developed symptom management, and a clearer understanding of lifestyle factors mean that most people with MS today can expect a future shaped, but not defined, by the condition.

The most useful steps after a diagnosis are usually the simplest: build a relationship with a neurology team you trust, learn about your particular type of MS, start and stay on a treatment plan that fits your situation, address symptoms as they appear rather than waiting, and look after the broader pieces of your health — sleep, activity, mood, and relationships. MS care today is a partnership, and the decisions ahead are best made with full information and the right specialist support around you.